![Truvadax400_0_0](https://www.hivplusmag.com/media-library/truvadax400-0-0.jpg?id=32665379&width=1200&height=900)
Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideoOut 100
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2024 Pride Publishing Inc.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Private Policy and Terms of Use.
The Food and Drug Administration has approved Truvada for use in reducing the risk of sexual transmission of HIV.
Truvada can be used as a Pre-exposure Prophylaxis, commonly known as PrEP. The FDA recommended Monday that Truvada, which is also an antiretrovial medication, be used "in combination with safer sex practices to prevent sexually acquired HIV infection in adults at high risk. They warned, however, that Truvada alone, even when taken daily, cannot be a substitute for safe sex practices.
"Today’s approval marks an important milestone in our fight against HIV," FDA Commissioner Margaret A. Hamburg, M.D. said in a statement. "Every year, about 50,000 U.S. adults and adolescents are diagnosed with HIV infection, despite the availability of prevention methods and strategies to educate, test, and care for people living with the disease. New treatments as well as prevention methods are needed to fight the HIV epidemic in this country."
A study to evaluate the effectiveness of Truvada as PrEP involved a sampling of 2,499 HIV-negative men and transgender women who have sex with men with evidence of high risk behavior for HIV infection such as inconsistent or no condom use during sex with a partner of positive or unknown HIV status, a high number of sex partners, and exchange of sex for commodities. The study showed Truvada was effective in reducing the risk of HIV infection by 42% versus the placebo. Another study of 4,758 heterosexual couples where one partner is HIV-negative and the other is HIV-positive showed a 75% reduction of risk versus the placebo.
"For the first time, there is now a pill that can be prescribed to HIV-negative individuals at increased vulnerability for contracting the virus that can significantly reduce their risk of infection," Moises Agosto of the National Minority AIDS Council said Monday.
Agosto warns, however, that Truvada is by no means a panacea and is only effective when used in conjunction with traditional prevention and risk reduction strategies, such as condom usage." "Anti-retroviral medications, like Truvada, are extremely powerful drugs with the potential for serious side effects," Agosto continued. "As such, PrEP should only be used by individuals who are highly vulnerable to HIV infection, including those in sero-discordant couples, sex workers and gay men. Its efficacy is also directly related to an individual’s adherence to a regimen, and should only be used by those who can commit to taking it regularly. Finally, use of PrEP by individuals who may already be HIV-positive could increase the risk of drug resistance." House Minority Leader Nancy Pelosi hailed the announcement in a statement Monday, and said she awaits the day that "AIDS is nothing but a terrible, terrible memory."
"The FDA’s historic decision to approve use of an antiretroviral drug for HIV prevention by individuals at high-risk of infection provides us with an effective new weapon in our fight against HIV/AIDS," she added. "We must employ each and every strategy that reduces the chances of acquiring HIV as part of a comprehensive approach to save lives in the United States and around the world. It’s a source of pride to me and my constituents that some of this groundbreaking research was conducted at San Francisco’s Gladstone Institutes."
Michael Weinstein of the AIDS Healthcare Foundation see the FDA's approval of Truvada without a precursory HIV test as a "wreckless" move that "will ultimately set back years of HIV prevention efforts." He added, "From the beginning we believe there was a rush to judgment by government officials and others in favor of such approval despite decidedly mixed studies offered in support. And while FDA recommends a negative HIV test prior to use of Truvada as PrEP and states that use by people with an ‘…unknown or HIV positive status…’ is ‘contraindicated,’ it in no way actually requires HIV testing in any manner—just strengthening of the ‘Boxed Warning’ on Gilead’s packaging."
The announcement comes just two weeks after the FDA approved at-home rapid HIV tests.
Want more breaking equality news & trending entertainment stories?
Check out our NEW 24/7 streaming service: the Advocate Channel!
Download the Advocate Channel App for your mobile phone and your favorite streaming device!
From our Sponsors
Most Popular
Before AIDS, gay artist Rex drew hot men on the prowl — then he disappeared
April 11 2024 3:15 PM
Diets that mimic fasting reverse aging: study
March 07 2024 5:28 PM
PrEP without a prescription now a reality in California
February 06 2024 8:37 PM
Injectable HIV treatment, prevention: Everything you need to know
March 26 2024 3:28 PM
8 dating tips for gay men from a gay therapist
March 21 2024 2:50 PM
Happy national foreskin day!
April 04 2024 1:45 PM
The science behind U=U has been liberating people with HIV for years
June 04 2024 3:31 PM
Scarlet fever: exploring our fascination with blood
March 13 2024 1:47 PM
On Anal Sex Day, crack up with The Bottom's Digest
April 18 2024 10:22 AM
Plus: Featured Video
Latest Stories
Activist and philanthropist Bruce Bastian dies at 76
June 26 2024 1:28 PM
Yes, HIV-positive people can safely breastfeed
June 26 2024 12:59 PM
Exclusive: We kiki with Q from 'RuPaul's Drag Race'
June 24 2024 11:37 AM
Court rules to keep PrEP coverage under Obamacare
June 21 2024 5:42 PM
In honor of Juneteenth 2024, meet The Normal Anomaly
June 19 2024 1:39 PM
What is Juneteenth?
June 19 2024 11:30 AM
As Pride party season begins, the CDC urges mpox vaccinations
May 16 2024 6:52 PM
Advocacy in action with AIDSWatch
May 09 2024 12:30 PM
The Talk: Thriving with HIV
May 08 2024 10:45 AM
The Talk: What HIV isn’t
May 07 2024 10:48 AM
The Talk: Finding balance with HIV
May 06 2024 10:51 AM
Justice Dept plans to reschedule marijuana as a lower-risk drug
May 03 2024 2:40 PM
The Talk: Starting your journey with HIV
May 03 2024 2:00 PM
Why is a mother’s mental health so important? A doctor explains
May 01 2024 1:38 PM
Walmart to close all of its health care clinics
April 30 2024 12:30 PM
Vampire facial spa infected several women with HIV
April 29 2024 7:26 PM